Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinecatechins 10% Ointment for Superficial Basal Cell Carcinoma
NCT02029352Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Nov 2014
- Primary completion
- Sep 2015
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Theaphenon E in basal cell carcinoma (BCC), sponsored by Maastricht University Medical Center+. Started Nov 2014; status: completed.
02
Drugs
Theaphenon E
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT02029352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029352.